Safe Orthopaedics (France) Performance
| ALSAF Stock | EUR 0.05 0 5.44% |
The entity has a beta of 2.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Safe Orthopaedics will likely underperform. At this point, Safe Orthopaedics has a negative expected return of -1.91%. Please make sure to validate Safe Orthopaedics' potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Safe Orthopaedics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Safe Orthopaedics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 2.4 M | |
| Total Cashflows From Investing Activities | -3 M |
Safe |
Safe Orthopaedics Relative Risk vs. Return Landscape
If you would invest 37.00 in Safe Orthopaedics SA on September 24, 2024 and sell it today you would lose (31.61) from holding Safe Orthopaedics SA or give up 85.43% of portfolio value over 90 days. Safe Orthopaedics SA is generating negative expected returns and assumes 14.365% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Safe on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Safe Orthopaedics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Safe Orthopaedics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Safe Orthopaedics SA, and traders can use it to determine the average amount a Safe Orthopaedics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1329
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALSAF |
Estimated Market Risk
| 14.37 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.91 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Safe Orthopaedics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Safe Orthopaedics by adding Safe Orthopaedics to a well-diversified portfolio.
Safe Orthopaedics Fundamentals Growth
Safe Stock prices reflect investors' perceptions of the future prospects and financial health of Safe Orthopaedics, and Safe Orthopaedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Safe Stock performance.
| Return On Equity | -639.4 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (1.35) % | |||
| Current Valuation | 10.42 M | |||
| Shares Outstanding | 79.68 M | |||
| Price To Book | 0.40 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 4.56 M | |||
| EBITDA | (5.2 M) | |||
| Cash And Equivalents | 913 K | |||
| Cash Per Share | 0.82 X | |||
| Total Debt | 5.28 M | |||
| Debt To Equity | 4.38 % | |||
| Book Value Per Share | (92.04) X | |||
| Cash Flow From Operations | (6.26 M) | |||
| Earnings Per Share | (11,536) X | |||
| Total Asset | 14.88 M | |||
About Safe Orthopaedics Performance
Assessing Safe Orthopaedics' fundamental ratios provides investors with valuable insights into Safe Orthopaedics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Safe Orthopaedics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company was founded in 2010 and is headquartered in ragny-sur-Oise, France. SAFE ORTHOPAEDICS operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 134 people.Things to note about Safe Orthopaedics performance evaluation
Checking the ongoing alerts about Safe Orthopaedics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Safe Orthopaedics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Safe Orthopaedics generated a negative expected return over the last 90 days | |
| Safe Orthopaedics has high historical volatility and very poor performance | |
| Safe Orthopaedics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 4.56 M. Net Loss for the year was (6.71 M) with profit before overhead, payroll, taxes, and interest of 2.57 M. | |
| Safe Orthopaedics SA has accumulated about 913 K in cash with (6.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Safe Orthopaedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Safe Orthopaedics' stock is overvalued or undervalued compared to its peers.
- Examining Safe Orthopaedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Safe Orthopaedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Safe Orthopaedics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Safe Orthopaedics' stock. These opinions can provide insight into Safe Orthopaedics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Safe Stock Analysis
When running Safe Orthopaedics' price analysis, check to measure Safe Orthopaedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safe Orthopaedics is operating at the current time. Most of Safe Orthopaedics' value examination focuses on studying past and present price action to predict the probability of Safe Orthopaedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safe Orthopaedics' price. Additionally, you may evaluate how the addition of Safe Orthopaedics to your portfolios can decrease your overall portfolio volatility.